These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 912644)
21. The treatment of primary central nervous system lymphoma in 122 immunocompetent patients: a population-based study of successively treated cohorts from the British Colombia Cancer Agency. Shenkier TN; Voss N; Chhanabhai M; Fairey R; Gascoyne RD; Hoskins P; Klasa R; Morris J; O'Reilly SE; Pickles T; Sehn L; Connors JM Cancer; 2005 Mar; 103(5):1008-17. PubMed ID: 15651059 [TBL] [Abstract][Full Text] [Related]
22. Combination chemotherapy for small cell carcinoma of the lung. Gilby ED; Bondy PK; Morgan RL; McElwain TJ Cancer; 1977 May; 39(5):1959-66. PubMed ID: 192442 [TBL] [Abstract][Full Text] [Related]
23. Intravenous methotrexate as central nervous system (CNS) prophylaxis is associated with a low risk of CNS recurrence in high-risk patients with diffuse large B-cell lymphoma. Abramson JS; Hellmann M; Barnes JA; Hammerman P; Toomey C; Takvorian T; Muzikansky A; Hochberg EP Cancer; 2010 Sep; 116(18):4283-90. PubMed ID: 20564149 [TBL] [Abstract][Full Text] [Related]
24. First, second and third line chemotherapy programs in metastatic breast carcinoma. Rizel S; Sulkes A; Gez E; Brufman G; Biran S Isr J Med Sci; 1981; 17(9-10):946-53. PubMed ID: 6171542 [TBL] [Abstract][Full Text] [Related]
25. [Therapeutic management of central nervous system lymphomas in a single hematological institute]. Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012 [TBL] [Abstract][Full Text] [Related]
27. Chemotherapy of metastatic breast cancer in postmenopausal women: a controlled trial of cyclophosphamide versus a five-drug combination of cyclophosphamide, vincristine, methotrexate, 5-fluorouracil and prednisone. Mouridsen HT; Palshof T Prog Clin Biol Res; 1977; 12():459-66. PubMed ID: 335404 [No Abstract] [Full Text] [Related]
28. [Bullous form of malignant histiocytosis]. Laroche L; Leverger G; Cazin B; Daniel MT; Flandrin G; Schaison G; Civatte J Ann Dermatol Venereol; 1985; 112(9):729-30. PubMed ID: 3841470 [No Abstract] [Full Text] [Related]
29. Multidrug chemotherapy in pulmonary treatment of osteosarcoma. Sutow WW; Gehan EA; Vietti TJ; Frias AE; Dyment PG J Bone Joint Surg Am; 1976 Jul; 58(5):629-33. PubMed ID: 1084348 [TBL] [Abstract][Full Text] [Related]
30. Malignant histiocytosis. Clinical findings and therapy. Huhn D; Meister P; Wilmanns W Klin Wochenschr; 1980 Jan; 58(1):31-5. PubMed ID: 7374094 [TBL] [Abstract][Full Text] [Related]
31. Diffuse aggressive lymphomas: increased survival after alternating flexible sequences of proMACE and MOPP chemotherapy. Fisher RI; DeVita VT; Hubbard SM; Longo DL; Wesley R; Chabner BA; Young RC Ann Intern Med; 1983 Mar; 98(3):304-9. PubMed ID: 6600902 [TBL] [Abstract][Full Text] [Related]
32. A case of histiocytic medullary reticulosis (HMR): response to combination chemotherapy. McCann SR; Daly H; Weir DG; Temperley IJ Ir J Med Sci; 1980 Jan; 149(1):23-5. PubMed ID: 6155361 [No Abstract] [Full Text] [Related]
33. Chemotherapy for breast cancer. Allegra JC; Lippman ME Compr Ther; 1979 Feb; 5(2):13-7. PubMed ID: 428200 [TBL] [Abstract][Full Text] [Related]
34. Prolonged single-agent versus combination chemotherapy in indolent follicular lymphomas: a study of the cancer and leukemia group B. Peterson BA; Petroni GR; Frizzera G; Barcos M; Bloomfield CD; Nissen NI; Hurd DD; Henderson ES; Sartiano GP; Johnson JL; Holland JF; Gottlieb AJ J Clin Oncol; 2003 Jan; 21(1):5-15. PubMed ID: 12506163 [TBL] [Abstract][Full Text] [Related]
35. Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphocytic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/methotrexate-cytarabine regimen. Weiser MA; Cabanillas ME; Konopleva M; Thomas DA; Pierce SA; Escalante CP; Kantarjian HM; O'Brien SM Cancer; 2004 Mar; 100(6):1179-85. PubMed ID: 15022284 [TBL] [Abstract][Full Text] [Related]
36. Long-term follow-up of patients with intermediate or high-grade non-Hodgkin lymphoma treated with a combination of cyclophosphamide, epirubicin, vincristine, and prednisone. Rossini F; Terruzzi E; Perego D; Miccolis I; Rivolta F; Manca E; Pogliani EM Cancer; 2004 Jan; 100(2):350-5. PubMed ID: 14716771 [TBL] [Abstract][Full Text] [Related]
37. Primary central nervous system lymphoma: Retrospective analysis of 34 cases in a single centre. Wang H; Wang M; Wei J; Wang L; Mao L; Jin J J Int Med Res; 2018 Feb; 46(2):883-894. PubMed ID: 28984175 [TBL] [Abstract][Full Text] [Related]
38. Combination chemotherapy. Old LJ; Krakoff IH Clin Bull; 1975; 5(3):120-3. PubMed ID: 1227737 [No Abstract] [Full Text] [Related]
39. Combination chemotherapy of advanced, diffuse, non-Hodgkin's lymphoma: results with cyclo-phosphamide, adriamycin, vincristine, prednisone, and bleomycin (CHOP-Bleo). Case DC J Maine Med Assoc; 1979 Sep; 70(9):348-50, 352, 368. PubMed ID: 92513 [No Abstract] [Full Text] [Related]
40. First-line treatment for primary testicular diffuse large B-cell lymphoma with rituximab-CHOP, CNS prophylaxis, and contralateral testis irradiation: final results of an international phase II trial. Vitolo U; Chiappella A; Ferreri AJ; Martelli M; Baldi I; Balzarotti M; Bottelli C; Conconi A; Gomez H; Lopez-Guillermo A; Martinelli G; Merli F; Novero D; Orsucci L; Pavone V; Ricardi U; Storti S; Gospodarowicz MK; Cavalli F; Sarris AH; Zucca E J Clin Oncol; 2011 Jul; 29(20):2766-72. PubMed ID: 21646602 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]